GYN Malignancies Flashcards
Name the 3 most common gynecologic malignancies in the order of prevalence.
- adenocarcinoma of the endometrium
- epithelial ovarian cancer
- squamous cell carcinoma of the cervix
What are the risk factors of endometrial cancer?
atypical hyperplasia
unopposed estrogen
obesity
nulliparous
late menopause
diabetes
HTN
Contrast type 1 and type 2 endometrial cancers
type 1 is estrogen related, type 2 is estrogen unrelated
type 1 occurs in younger patients, type 2 in older patients
type 1 are typically heavier, type 2 thinner
type 1 is usually low grade, type 2 high grade (aggressive)
type 1 more curable/ longer pre-cancer phase, type 2 potential basis (lynch)
type 1 often have PTEN and KRAS mutations, type 2 often have p53 mutations
type 1 has an endometriod histology and type 2 has serous histology
What is the histologic appearance of type 1 cancers?
endometrial hyperplasia- increased glandular tissue and increasingly less regular architecture (cribriform- back to back)
nuclei become larger, rounder and nucleoli are more prominent
What is the histologic appearance of endometrial carcinoma type 2?
instead glands there is papillary structure, malignant cells line the surface of glands with a high N/C ratio and more pleomorphism
Who needs an endometrial biopsy to rule out endometrial cancer?
any one with post menopausal bleeding
perimenopausal inter menstrual bleeding
bleeding with history of involution
postmenopausal women with Pap test
thickened endometrial stripe via sonography
What are different surgical techniques that are used to control endometrial cancer based on pathology present?
can include peritoneal cytology, TAH/BSO, pelvic and aortic lymph node dissection
purpose of procedure: defines extent of disease minimizes over/under treatment min. increases perioperative morbidity/mortality decreases over rx risk and cost allows comparison of therapeutic results
Wha is the usual treatment for endometrial cancer regarding adjuvant postoperative therapy?
whole pelvic radiation and vaginal cuff boost, mostly for stage II + and with nodal involvement
can reduce recurrence by up to 50% with 25-30d treatment
What are risk factors for ovarian cancer?
increased age (post-menopausal) family history infertility/ low parity uninterrupted ovulation personal cancer history, esp. breast cancer
decreased risk: OCPs, pregnancy, tubal ligation, breast feeding
Serious tumor is generated from which ovarian precursor?
surface epithelial cells (represents 65-70% of tumors)
*note many “ovarian” epithelial carcinomas are thought to arise form the fibrillated end of the uterine tube
Contrast the mutations found in low and high grade epithelial ovarian cancer.
low grade: KRAS, BRAF, PTEN, B-catenin
high grade p53
Is CA125 a reliable screen for ovarian cancer?
although CA125 is elevated in most advanced epithelial ovarian cancers it has poor sensitivity and poor specificity and is only used in screening high risk population (increase pre-test probability)
What is the optimal therapy for ovarian cancer?
(aggressive surgery yields best survival results-optimal cytoreduction)
TAH and BSO +/- infra colic omentectomy, peritoneal samples from pelvis, gutters and diaphragm surfaces, pelvic and aortic lymph node dissection for staging
in younger women, reproductive conservation may be appropriate
When is chemotherapy recommended for ovarian cancer?
all patients should receive a taxmen and a platinum, 73% will respond although many women with advanced disease will experience recurrence
What are important points for follow up of ovarian cancer/
recto-vaginal pelvic exam and CA125/3-4mo for 2 years
discuss HRT, diet and exercise and continue general health maintenance (mammography, pap smear, bone density, CRC, cholesterol etc.)